🔥🔥🔥 JOIN OUR STARTUP AMBASSADOR PROGRAM 🔥🔥🔥
    📣 Spread the news & get a PRO membership 3 months for FREE with all features🚀📈💵500 vouchers left • 3 months free
    IPSA logo

    IPSA

    VC · Paris (France)

    VC
    Seed
    Series A
    AI
    Cloud/SaaS

    Sign up free to access full profile and submit your pitch.

    About

    IPSA is a private equity and venture capital firm specializing in seed, startup, early-stage, mid venture, later stage, growth capital, and pre-IPO investments. The firm prefers to invest in life sciences, Internet, telecommunications, biotechnology, medical, energy, chemistry, information and communications technology, water purification, natural resources, cleantech, capital goods, and distribution sectors. In life science sector it further invests in clinical-stage drug development, medical devices, drug delivery, and development services. In information and communications technology sector the firm invests with a focus in content, software, enabling technology, and infrastructure. In natural resources sector it invests further in exploration and production and renewable energy and clean technology. The firm seeks to invest in companies based in European Union with a focus on France, the U.K., Germany, the Netherlands, and Denmark and it also invest occasionally in companies based in North America. It seeks to invest in the first instance between €1 million ($1.33 million) and €5 million ($6.68 million) for a minority stake in the company. It seeks to invest in companies with revenues between €10 million ($13.37 million) and €100 million ($133.73 million). The firm prefers to be the lead or a co-lead investor in its portfolio companies. It seeks to hold a board seat in its portfolio companies. The firm exits from its portfolio companies through an IPO or trade sale within five years. The firm was formerly known as Innoven Partenaires S.A. IPSA was founded in 1997 and is based in Paris, France.

    Visit website ↗

    Investment Criteria

    Sign up free to see full investment criteria and submit your pitch.

    Min. Ticket Size
    $1,330,000
    Max. Ticket Size
    $6,680,000
    Min. Revenue (ARR)
    $13,370,000
    Investment Stage
    Seed
    Series A
    Series B
    Series C
    Regions
    Eastern Europe
    Southern Europe
    North America
    Western Europe
    Northern Europe

    We use cookies to enhance your experience. Read our Privacy Policy